Accordingly, a report of Finish data demonstrated the risk for PCa diagnosis associated with a positive FH did not substantially increase among patients who underwent PSA screening and subsequent prostate biopsy.[25] Therefore, further investigation is warranted to elucidate the association between FH and PSA screening. This evidence concerns the gene FH and posterior cortical atrophy.